Abstracts tagged "psoriatic arthritis and ultrasonography"

Abstract Number: 652 • 2018 ACR/ARHP Annual Meeting
Disease Interception in Psoriasis Patients with Subclinical Joint Inflammation By Interleukin 17 Inhibition with Secukinumab – Data from a Prospective Open Label Study
Eleni Kampylafka¹, Isabelle Oliveira¹, Christina Linz², Veronika Lerchen¹, Matthias Englbrecht¹, David Simon³, Michael Sticherling⁴, Juergen Rech⁵, Arnd Kleyer³, Georg Schett⁶ and Axel J. Hueber³, ¹Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, ²Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, e, Germany, ³Department of Internal Medicine 3—Rheumatology and Immunology, Friedrich-Alexander-University Erlangen–Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, ⁴Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, ⁵Universitätsklinikum Erlangen, Erlangen, Germany, ⁶Department of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany
Background/Purpose: Musculoskeletal changes precede the onset of psoriatic arthritis (PsA). A subset of psoriasis patients is characterized by arthralgia as well as inflammatory changes in…
Abstract Number: 1208 • 2018 ACR/ARHP Annual Meeting
Indicators for Active Musculoskeletal Ultrasound Findings of Psoriatic Arthritis Vary on Each Body Part
Shuji Sumitomo¹, Shoko Tateishi², Yoko Soroida³, Harumi Shirai⁴, Tomomi Iwai⁵, Kuimiko Ono⁶, Jun Hirose⁶, Ayumi Yoshizaki⁷, Yoshihide Asano⁸, Shinichi Sato⁹, Sakae Tanaka⁶, Hitoshi Ikeda⁵, Keishi Fujio¹, Kazuhiko Yamamoto¹⁰ and Hiroko Kanda¹¹, ¹Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, ²Department of Immunotherapy Management, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, ³Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, ⁴Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, ⁵Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, ⁶Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan, ⁷Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, ⁸Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, ⁹The University of Tokyo, Department of Dermatology, Tokyo, Japan, ¹⁰Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, ¹¹Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan
Background/Purpose: Although some global composite measures (DAPSA, DAS28) reflect musculoskeletal ultrasound (MSUS) findings of psoriatic arthritis (PsA), there is little knowledge on how to predict…
Abstract Number: 882 • 2017 ACR/ARHP Annual Meeting
A New Model of Care for Improving Early Rheumatology Access of Psoriatic Arthritis Patients
Keith Colaco^1,2, Dana Jerome³, Jensen Yeung^4,5, Noah Ivers^6,7,8, Carol Kitai⁷, Chandra Farrer³ and Lihi Eder^1,9, ¹Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, ²Institute of Medical Science, University of Toronto, Toronto, ON, Canada, ³Rheumatology, Women's College Hospital, Toronto, ON, Canada, ⁴Dermatology, Women's College Hospital, Toronto, ON, Canada, ⁵University of Toronto, Toronto, ON, Canada, ⁶Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁷Women's College Hospital, Toronto, ON, Canada, ⁸Family and Community Medicine, University of Toronto, Toronto, ON, Canada, ⁹Medicine, University of Toronto, Toronto, ON, Canada
Background/Purpose: The prevalence of undiagnosed psoriatic arthritis (PsA) in psoriasis patients is high, with delays in diagnosis contributing to poor patient outcomes. We aimed to…
Abstract Number: 1551 • 2017 ACR/ARHP Annual Meeting
Avoidance of Physical Activity Leads to Reduced Inflammatory Enthesitis on Ultrasound
Kim Wervers¹, Irene Herrings¹, Jolanda J. Luime², Marlies Moed¹, Ilja Tchetverikov³, Andreas H. Gerards⁴, J.M.W. Hazes⁵ and Marijn Vis², ¹Erasmus Medical Centre, Rotterdam, Netherlands, ²Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands, ³Albert Schweitzer Hospital, Dordrecht, Netherlands, ⁴Sint Franciscus Vlietland Group, Schiedam, Netherlands, ⁵Department of Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands
Background/Purpose: Enthesitis is one of the manifestations of psoriatic arthritis (PsA), but no clear definition for the diagnosis exists. To further evaluate the added value…
Abstract Number: 2883 • 2017 ACR/ARHP Annual Meeting
Prevalence of Cardiovascular Risk Factors and Subclinical Cardovacular Disease in Psoriatic Arthritis
María Paz Martínez-Vidal¹, Cristina Fernández-Carballido², Mariano Andres³, Vega Jovaní⁴, Carlos Santos⁵, Maria Nieves Martínez Alberola⁶, Francisca Sivera⁷ and Raquel Martin-domenech⁶, ¹Rheumatology, Hospital general universitario de Alicante, Alicante, Spain, ²Hospital General Universitario de Elda, Elda, Spain, ³RHEUMATOLOGY, Hospital general universitario de Alicante, Alicante, Spain, ⁴Reumatología, Hospital general universitario de Alicante, Alicante, Spain, ⁵Rheumatology, Hospital de Alcoy, Alcoy, Spain, ⁶Rheumatology, Hospital General Universitario de Elda, Elda, Spain, ⁷Sección de Reumatología, Hospital General Universitario de Elda., Elda, Spain
Background/Purpose: SCORE tables underestimate the Cardiovascular Risk (CVR) for patients with Rheumatoid Arthritis (RA) and EULAR recommends multiplying by 1.5 the CVR obtained from them…
Abstract Number: 960 • 2016 ACR/ARHP Annual Meeting
Ultrasonographic Improvement of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated with Ustekinumab for Chronic Plaque Psoriasis: A 52-Week, Prospective, Open Label, Controlled Cohort Study
Laura Savage¹, Mark Goodfield², Elizabeth M.A. Hensor³, Paul Emery³ and Dennis McGonagle⁴, ¹NIHR Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ²Department of Dermatology, Leeds Centre for Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ³NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, ⁴Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom
Background/Purpose: Subclinical enthesopathy is recognised in up to 50% of psoriasis patients and is thought to precede inflammatory PsA. It is not known if effective…
Abstract Number: 1746 • 2015 ACR/ARHP Annual Meeting
Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis
Brigitte Michelsen¹, Andreas P Diamantopoulos^1,2, Hilde Berner Hammer³, Dag Magnar Soldal⁴, Arthur Kavanaugh⁵ and Glenn Haugeberg^1,6,7, ¹Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, ²Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, ³Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, ⁵University of California, San Diego School of Medicine, LaJolla, CA, ⁶Rheumatology, Martina Hansens Hospital, Gjettum, Norway, ⁷Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway
Background/Purpose: Coping may be defined as the set of adaptive processes a patient uses to live well with aspects of disease such as pain. Coping…
Abstract Number: 1696 • 2015 ACR/ARHP Annual Meeting
Score Classification Underestimates the Real Cardiovascular Risk in Psoriatic Arthritis Patients
Maria Paz Martínez-Vidal¹, Cristina Fernández-Carballido², Francisca Sivera³, Raquel Martín-Doménech¹, Nieves Martínez-Alberola¹ and Alejandro San Martin⁴, ¹Rheumatology, Hospital General Universitario Elda, ELDA, Spain, ²Rheumatology, Hospital General Universitario de Elda, Elda (Alicante), Spain, ³Reumatología, Hospital General Universitario de Elda, Alicante, Spain, ⁴Rheumatology, Univesity General Hospital, ELDA, Spain
Background/Purpose: SCORE tables underestimate the Cardiovascular Risk (CVR) for patients with Rheumatoid Arthritis (RA) and EULAR recommends multiplying by 1.5 the CVR obtained from them…
Abstract Number: 2614 • 2014 ACR/ARHP Annual Meeting
Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments
Agnes Szentpetery¹, Muhammad Haroon², Eileen O'Flynn¹, Phil Gallagher¹, Shafeeq Alraqi¹ and Oliver FitzGerald¹, ¹Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ²Newmarket On Fergus, Cork University Hospital, Cork, Ireland
Background/Purpose 68 tender (TJC) and 66 swollen joint counts (SJC) are recommended for disease activity assessment in psoriatic arthritis (PsA). However there are time constraints…
Abstract Number: 2503 • 2013 ACR/ARHP Annual Meeting
IL-17+ CD8+ T Cells Are Enriched In The Joints Of Patients With Psoriatic Arthritis and Correlate With Markers Of Disease Activity and Joint Damage Progression
Bina Menon^1,2, Nicola J. Gullick³, Hayley G. Evans⁴, Gina J. Walter⁴, Megha Rajasekhar⁴, Toby Garrood², Leonie S. Taams⁴ and Bruce W. Kirkham², ¹Centre for Cellular and Molecular Biology of Inflammation, King's College London, London, United Kingdom, ²Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, ³Rheumatology, King's College Hospital Foundation NHS Trust, London, United Kingdom, ⁴Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, United Kingdom
Background/Purpose: Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) have clear differences in clinical, radiological and genetic features, suggesting that the immunopathology of the conditions may…
Abstract Number: 1111 • 2013 ACR/ARHP Annual Meeting
Utility Of An Ultrasound Enthesitis Score As a Complementary Diagnostic Tool To Detect Psoriatic Arthritis In Patients With Psoriasis
Tomas Cazenave¹, Christian A. Waimann², Gustavo Citera¹ and Marcos G. Rosemffet¹, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: To evaluate the prevalence of subclinical enthesopathy in psoriasis (Ps) patients compared with psoriatic arthritis (PsA) and healthy controls (HC), and to assess the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].